文献速递产科母胎医学

肥胖产妇剖宫产切口负压治疗随机对照试验

Randomized controlled trial of single-use negative-pressure wound therapy dressings in morbidly obese patients undergoing cesarean delivery.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-05-28

本研究为单中心随机对照试验,纳入Ⅲ级肥胖(BMI≥40 kg/m²)剖宫产患者,比较预防性负压伤口治疗敷料与标准外科敷料对术后伤口并发症的影响。

要点

  • 在Ⅲ级肥胖剖宫产患者中,预防性负压伤口治疗未显著降低伤口并发症。
  • 试验因入组缓慢及中期分析显示获益可能性低而提前终止。

核心结论

  • 预防性负压伤口治疗装置用于Ⅲ级肥胖剖宫产患者,未较标准外科敷料降低伤口并发症。

研究设计与样本

  • 单中心、平行、随机对照试验,纳入BMI≥40 kg/m²的剖宫产患者,按1:1随机分配至标准敷料或负压伤口治疗装置。
  • 计划样本量242例,基于检测复合伤口结局下降50%的把握度,假设基线伤口并发症率为30%。
  • 实际入组212例,其中110例剖宫产后随机(标准组55例,负压组55例);结局评估对治疗分组设盲。

主要发现

  • 因入组率低及中期分析显示出现临床显著获益的可能性低,试验提前终止。

临床怎么用

  • 对于Ⅲ级肥胖剖宫产患者,预防性使用负压伤口治疗敷料未显示优于标准外科敷料,不应常规推荐用于降低伤口并发症。

局限性

  • 试验因入组缓慢和中期分析而提前终止,实际样本量(110例随机)低于计划样本量(242例),可能影响统计效能。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The single-use negative-pressure wound therapy dressings are designed to use over a closed surgical wound. Early prospective studies suggested that these dressings may be of potential benefit in reducing cesarean wound complications. OBJECTIVE: This study aimed to test the hypothesis that incisional negative-pressure wound therapy decreases postoperative wound morbidity compared with standard surgical dressing in patients with class III obesity undergoing cesarean delivery. STUDY DESIGN: In a single-site, parallel, randomized controlled trial, participants with class III obesity (body mass index ≥40 kg/m2) were recruited to participate in the study. Patients were consented in the ambulatory obstetrical units, on admission to the antepartum service, and on labor and delivery before active labor. Patients who had a cesarean delivery were randomized to either the standard surgical dressing or a prophylactic negative-pressure wound therapy device. The randomization was achieved using permuted blocks of 4, 6, and 8 in a 1:1 allocation ratio. The primary outcome was a composite outcome of wound complications. The planned enrollment of 242 subjects was based on the power to detect a 50% decrease in the composite wound outcome, assuming a 30% baseline wound morbidity rate for this population. The outcomes were assessed by study staff blinded to the patient's treatment arm. RESULTS: An unplanned interim analysis was performed because of the slow enrollment and publication of larger trials showing no benefit of the negative-pressure wound therapy. Of 411 eligible patients during the study period, 212 participants with class III obesity were enrolled. Of these, 110 underwent cesarean delivery and were subsequently randomized (55 to standard dressing and 55 to prophylactic negative-pressure wound therapy device). The primary outcome occurred in 29.1% in the standard surgical dressing compared with 20% in the negative-pressure wound therapy group (risk difference, 9.1%; 95% confidence interval, -8.3 to 25.8%; P=.38). The study was stopped early because of a low enrollment rate and lower likelihood of seeing a clinically significant benefit. CONCLUSION: The trial was stopped after an unplanned, interim analysis showed the use of a prophylactic negative-pressure wound therapy device used for cesarean delivery did not reduce wound complications compared with a standard surgical dressing.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Peterson AT, Bakaysa SL, Driscoll JM, et al. Randomized controlled trial of single-use negative-pressure wound therapy dressings in morbidly obese patients undergoing cesarean delivery. Am J Obstet Gynecol MFM. 2021. PMID: 34058423. doi:10.1016/j.ajogmf.2021.100410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。